Publikationen in Zusammenarbeit mit Forschern von Saarland University (13)

2024

  1. Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023

    Transplant Infectious Disease, Vol. 26, Núm. 1

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021

    Transplant Infectious Disease, Vol. 24, Núm. 6

  2. Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation

    The oncologist, Vol. 27, Núm. 7, pp. e561-e570

2019

  1. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

    Critical Reviews in Oncology/Hematology, Vol. 134, pp. 39-45

2017

  1. Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis

    American Heart Journal, Vol. 193, pp. 46-54

2016

  1. Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials

    Cardiovascular Revascularization Medicine, Vol. 17, Núm. 5, pp. 295-301

2015

  1. Adjuvant bisphosphonate treatment in early breast cancer: Meta-analyses of individual patient data from randomised trials

    The Lancet, Vol. 386, Núm. 10001, pp. 1353-1361

  2. Consistency of benefit from an early invasive strategy after fibrinolysis: A patient-level meta-analysis

    Heart, Vol. 101, Núm. 19, pp. 1554-1561

2014

  1. A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer

    European Urology, Vol. 65, Núm. 3, pp. 516-520

  2. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: A pooled analysis of individual patient data

    The Lancet Oncology, Vol. 15, Núm. 4, pp. 406-414

  3. Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials

    American Heart Journal, Vol. 168, Núm. 5, pp. 757-765.e3

2010

  1. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: A meta-analysis

    European Heart Journal, Vol. 31, Núm. 17, pp. 2156-2169